18-02-2026 16:52 via drugs.com

Updated Pan-Tumor Guidelines Issued for Assessing Pathologic Response

WEDNESDAY, Feb. 18, 2026-- In guidelines published in the February issue of the Annals of Oncology, updated recommendations are presented for a pan-tumor framework for evaluating residual viable tumor, necrosis, and regression after presurgical...
Read more »